Adhesion Molecules in CNS Disorders: Biomarker and Therapeutic Targets

E-ISSN： 1996-3181|12|3|392-404

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.3, 2013-05, pp. : 392-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease

By Ulbrich H. Eriksson E.E. Lindbom L.

Trends in Pharmacological Sciences, Vol. 24, Iss. 12, 2003-12 ,pp. : 640-647

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of steroids for CNS disorders

By Hamilton Niall M

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 10, 2001-10 ,pp. : 1523-1531

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Interference of Signalling Cascades of Axon Growth Inhibitory Molecules as Therapeutic Targets of CNS Lesions (Executive Editor: D. Bagnard)]

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2469-2469

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of new therapeutic targets for prevention of CNS inflammation

By Owens Trevor

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 203-215

Informa Healthcare

Access to resources Recommend Favorite

Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 596-600

Bentham Science Publishers

Access to resources Recommend Favorite